Reid Huber is an integral part of Third Rock Ventures, a venture capital firm dedicated to the biopharmaceutical. See sector focus and contact routes.
Reid Huber is an integral part of Third Rock Ventures, a venture capital firm dedicated to the biopharmaceutical and healthcare sectors. Third Rock Ventures is committed to the discovery, launch, building, and transformation of companies with the ultimate goal of delivering innovative medicines to patients. The firm's recent achievements underscore this mission, including the significant milestone of FDA approval for Otarmeni™, a groundbreaking gene therapy designed to address hearing loss. Additionally, Third Rock Ventures has celebrated the FDA approval of Aqvesme™, a new medicine developed to treat anemia. Their ongoing efforts also include the advancement of Syremis Therapeutics, a company focused on developing solutions for mental health challenges.
Every field above is read from the StartupFundraising investor directory — disclosed location, recorded investments and stated focus — and re-checked as filings arrive. Founders pair it with investors in Boston when building a target list.
Investors like Reid Huber · Full investor directory · Investor access · Company funding database